How can we best predict cardiovascular disease risk in type 1 diabetes? A comparison of risk equations

被引:0
|
作者
Saunders, R. [1 ]
Boye, K. [2 ]
Bae, J. [2 ]
Norrbacka, K. [3 ]
Timlin, L. [4 ]
Pollock, R. [1 ]
Valentine, W. [1 ]
机构
[1] Ossian Hlth Econ, Basel, Switzerland
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Eli Lilly & Co, Helsinki, Finland
[4] Eli Lilly & Co, Windlesham, Surrey, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
221
引用
收藏
页码:S100 / S100
页数:1
相关论文
共 50 条
  • [41] Cardiovascular Risk in Type 1 Diabetes Mellitus
    Jonathan Schofield
    Jan Ho
    Handrean Soran
    Diabetes Therapy, 2019, 10 : 773 - 789
  • [42] Type 1 diabetes mellitus and cardiovascular risk
    Jose Chillaron, Juan
    Francisco Cano, Juan
    Pedro-Botet, Juan
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2008, 20 (05): : 210 - 217
  • [43] Cardiovascular Risk Management in Type 1 Diabetes
    Teoh, I. H.
    Elisaus, P.
    Schofield, J. D.
    CURRENT DIABETES REPORTS, 2021, 21 (09)
  • [44] Cardiovascular Risk Management in Type 1 Diabetes
    I. H. Teoh
    P. Elisaus
    J. D. Schofield
    Current Diabetes Reports, 2021, 21
  • [46] Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes
    Dei Cas, Alessandra
    Aldigeri, Raffaella
    Mantovani, Alessandro
    Masulli, Maria
    Palmisano, Luisa
    Cavalot, Franco
    Bonomo, Katia
    Baroni, Marco Giorgio
    Cossu, Efisio
    Cavallo, Gisella
    Cimini, Flavia Agata
    Buzzetti, Raffaella
    Mignogna, Carmen
    Leonetti, Frida
    Bacci, Simonetta
    Trevisan, Roberto
    Morieri, Mario Luca
    Pollis, Riccardo Maria
    Targher, Giovanni
    de Kreutzenberg, Saula Vigili
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (09): : E789 - E798
  • [47] COMMUNICATION IN CARDIOVASCULAR DISEASE PREVENTION: HOW CAN WE MAKE THE CONCEPT OF RISK MORE MEANINGFUL?
    Bonner, C.
    McKinn, S.
    Lau, A.
    Jansen, J.
    Irwig, L.
    Glasziou, P.
    Doust, J.
    McCaffery, K.
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2016, 23 : S225 - S225
  • [48] Can we improve cardiovascular risk prediction beyond risk equations in the physician's office?
    Aboyans, Victor
    Criqui, Michael H.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2006, 59 (06) : 547 - 558
  • [49] Finerenone can modify cardiovascular risk in type 2 diabetes
    Pavlicek, Vojtech
    DIABETOLOGIE, 2023, 19 (06): : 786 - 788
  • [50] Type 2 diabetes and cardiovascular disease: Reducing the risk
    Bartels, David W.
    Davidson, Michael H.
    Gong, William C.
    JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (02): : S2 - S15